Paid Clinical Trials Paid Clinical Trials > Browse Categories > Pharma Companies > Baxter Healthcare

Baxter Healthcare

Baxter Healthcare

All Categories Pharma Companies » Baxter Healthcare


  • BAX 855 Dose-Escalation Safety Study

    Condition:   Hemophilia A
    Interventions:   Biological: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method;   Biological: PEGylated Recombinant Factor VIII
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation;   Baxter Innovations GmbH
    Recruiting - verified May 2012
  • Early High-volume Continuous Veno-venous Hemofiltration for Patients With Severe Acute Pancreatitis

    Condition:   Acute Pancreatitis
    Interventions:   Device: AN69 hemofilter;   Other: conventional treatments
    Sponsors:   Fourth Military Medical University;   Fourth Military Medical University
    Recruiting - verified May 2012
  • TBE Seropersistence up to 10 Years After First Booster in Adults

    Condition:   Tick-borne Encephalitis (TBE)
    Intervention:   Biological: FSME-IMMUN 0.5 ml
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified May 2012
  • Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)

    Conditions:   Subarachnoid Hemorrhage (SAH);   Tachycardia
    Intervention:  
    Sponsors:   Columbia University;   Columbia University;   Baxter Healthcare Corporation
    Enrolling by invitation - verified April 2012
  • Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation

    Condition:   Nutrition Support
    Interventions:   Other: Oliclinomel N4;   Other: Compounded ternary parenteral nutrition admixtures
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified April 2012
  • Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis

    Condition:   Systemic Lupus Erythematosus
    Intervention:   Drug: Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified March 2012
  • Cocktail Sedation Containing Propofol Versus Conventional Sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP)

    Condition:   Disorders of Gallbladder, Biliary Tract and Pancreas
    Intervention:   Drug: propofol
    Sponsors:   King Chulalongkorn Memorial Hospital;   King Chulalongkorn Memorial Hospital
    Completed - verified February 2012
  • Effect of Fibrin Sealant on Early Wound Healing

    Condition:   Periodontitis
    Interventions:   Drug: Fibrin Sealant;   Drug: Suture
    Sponsors:   Chhattisgarh Dental College and Research Institute;   Chhattisgarh Dental College and Research Institute;   Baxter Healthcare Corporation
    Recruiting - verified April 2012
  • Phase 3 IGIV, 10% in Alzheimer´s Disease

    Condition:   Alzheimer´s Disease
    Interventions:   Biological: Immune Globulin Intravenous (Human), 10% Solution;   Biological: Human albumin 0.25%
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified May 2012
  • Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

    Conditions:   Chronic Myocardial Ischemia;   Refractory Angina Pectoris;   (Advanced) Coronary Heart Disease
    Interventions:   Biological: Auto-CD34+ cells;   Biological: Placebo: Diluent used to suspend Auto-CD34+ cells;   Other: Standard of care
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified April 2012
  • The Effects of Pre-transplant Dialysis Modality on Post-transplant Events

    Conditions:   Delayed Function of Renal Transplant;   Primary Nonfunction of Renal Transplant;   Acute Rejection of Renal Transplant
    Intervention:  
    Sponsors:   Samsung Medical Center;   Ha Young Oh;   Baxter Healthcare Corporation
    Recruiting - verified January 2012
  • BAX 326 Surgery Study

    Condition:   Hemophilia B
    Intervention:   Biological: Recombinant factor IX
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation;   Baxter Innovations GmbH
    Recruiting - verified January 2012
  • Phase 1/2 Lyme Vaccine Study

    Condition:   Prophylaxis of Lyme Borreliosis
    Interventions:   Biological: Multivalent recombinant OspA Lyme Borreliosis Vaccine;   Biological: Multivalent recombinant OspA Lyme Borreliosis Vaccine;   Biological: Multivalent recombinant OspA Lyme Borreliosis Vaccine
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified January 2012
  • Evaluation of the Effectiveness of Daily Pulse Lavage Therapy in Chronic Wounds

    Condition:   Chronic Wounds
    Interventions:   Procedure: Pulse lavage treatment;   Other: Dressing changes
    Sponsors:   Northwestern University;   Northwestern University;   Baxter Healthcare Corporation
    Enrolling by invitation - verified February 2012
  • IVIG Treatment for Refractory Immune-Related Adult Epilepsy

    Conditions:   Epilepsy, Cryptogenic;   Epilepsy, Partial;   Seizure Disorder;   Autoimmune Diseases, Nervous System;   Limbic Encephalitis
    Intervention:   Drug: IVIG
    Sponsors:   Emory University;   Emory University;   Baxter Healthcare Corporation
    Enrolling by invitation - verified March 2012
  • Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

    Condition:   Primary Immunodeficiency Disorders
    Interventions:   Biological: Immune Globulin Infusion (Human), 10%;   Biological: Recombinant human hyaluronidase
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified May 2012
  • BAX 326 Pediatric Study

    Condition:   Hemophilia B
    Intervention:   Biological: Recombinant Factor IX
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation;   Baxter Innovations GmbH
    Recruiting - verified April 2012
  • TICACOS International

    Condition:   Mechanical Ventilation Complication
    Intervention:   Dietary Supplement: Indirect Calorimetry measurement of Resting Energy Expenditure .
    Sponsors:   Rabin Medical Center;   Rabin Medical Center;   Baxter Healthcare Corporation
    Recruiting - verified November 2011
  • Philips Pivotal Clinical Trial for MRI-HIFU of Uterine Fibroids

    Condition:   Uterine Fibroids
    Interventions:   Device: MR-HIFU treatment for ablation of uterine fibroids;   Device: Sham HIFU treatment
    Sponsors:   Philips Healthcare;   Philips Healthcare
    Not yet recruiting - verified May 2012
  • e-STEPS: Endotoxin-Associated Sterile Peritonitis Observational Study

    Condition:   Endotoxin-associated Sterile Peritonitis
    Intervention:  
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Not yet recruiting - verified November 2011
  • Osteoporosis and MRI Study in Hemophilia

    Conditions:   Bone Mineral Density;   Hemophilia A;   Hemophilia B
    Intervention:   Other: DXA scan + MRI
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Terminated - verified April 2012
  • Clinical Evaluation of Bedside Pulse Lavage Irrigation Device

    Condition:   Healthy
    Intervention:   Device: Pulsed lavage (Stryker Pulsavac Plus)
    Sponsors:   Northwestern University;   Northwestern University;   Baxter Healthcare Corporation
    Enrolling by invitation - verified October 2011
  • Immune Globulin Subcutaenous (Human), 20%

    Condition:   Primary Immunodeficiency Diseases (PID)
    Interventions:   Biological: Immune Globulin Subcutaneous (Human), 20%;   Biological: Immune Globulin Intravenous (Human), 10%;   Biological: Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified September 2011
  • Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty

    Conditions:   Knee Replacement Surgery;   Osteoarthritis
    Interventions:   Other: Standard of Care;   Drug: FLOSEAL Hemostatic Matrix
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified February 2012
  • Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment and Prevention of Bleeding Episodes in Von Willebrand Disease (VWD)

    Condition:   Von Willebrand Disease
    Intervention:   Biological: Recombinant von Willebrand factor (rVWF) with or without rFVIII (Advate)
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation;   Baxter Innovations GmbH
    Recruiting - verified March 2012
  • H5N1 Vaccine Study in Japanese Adults

    Condition:   H5N1 Influenza
    Intervention:   Biological: H5N1 (pre-)pandemic influenza vaccine (whole virion, Vero Cell derived, inactivated)
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation;   Baxter Innovations GmbH
    Active, not recruiting - verified September 2011
  • Early Prophylaxis Immunologic Challenge (EPIC) Study

    Condition:   Hemophilia A
    Intervention:   Biological: Recombinant antihemophilic factor, plasma/albumin-free method (rAHF-PFM)
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation;   Baxter Innovations GmbH
    Recruiting - verified December 2011
  • Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol

    Conditions:   Vascular Disease;   Hypertension;   Angina;   Cardiac Disease
    Interventions:   Drug: Esmolol;   Drug: Metoprolol
    Sponsors:   University Health Network, Toronto;   University Health Network, Toronto;   Baxter Healthcare Corporation
    Recruiting - verified August 2011
  • Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China

    Condition:   End Stage Renal Disease
    Interventions:   Other: Peritoneal Dialysis treatment;   Other: Hemodialysis treatment
    Sponsors:   Baxter Healthcare Corporation;   Baxter Healthcare Corporation
    Recruiting - verified August 2011

Main Menu
Clinical Trial Categories
Clinical Trial Locations